Long-Term Durability Standards In Implants.

Long-Term Durability Standards In Implants – Detailed Explanation With Case Laws

1. Introduction

Long-term durability standards in implants refer to the legal, scientific, technical and regulatory requirements that ensure implanted medical devices remain safe, effective and reliable throughout their intended useful life.

Medical implants include hip and knee replacements, dental implants, cardiac pacemakers, artificial heart valves, breast implants, vascular stents and spinal fixation devices.

These devices may remain inside the human body for several years or throughout a patient's lifetime. Therefore, their durability is essential for preventing premature failure, tissue damage, infection, inflammation, pain and additional surgical procedures.

In Canada, long-term implant durability is primarily governed by the Medical Devices Regulations, SOR/98-282, together with applicable international technical standards.

2. Meaning and Scope of Long-Term Durability Standards

Long-term durability standards establish requirements for evaluating whether implants can maintain their intended performance under normal and reasonably foreseeable conditions of use.

They address:

Mechanical strength and structural stability.

Resistance to corrosion and material degradation.

Biological compatibility.

Resistance to repeated mechanical stress.

Wear and tear.

Expected useful life.

Long-term clinical performance.

Post-market monitoring and failure reporting.

Durability does not mean that an implant must last forever. It means that the implant must remain safe and perform according to its intended purpose and projected useful life.

3. Legal and Regulatory Framework in Canada

A. Medical Devices Regulations, SOR/98-282

The Medical Devices Regulations establish the principal regulatory framework for implant safety and performance in Canada.

Section 10 establishes general safety and effectiveness requirements.

Section 12 requires devices to perform as intended by their manufacturers.

Section 13 addresses deterioration of device characteristics and performance during the projected useful life of the medical device.

Section 15 addresses material compatibility and associated risks.

These provisions require manufacturers to consider the expected lifespan of implants and ensure that deterioration does not adversely affect patient safety.

B. Health Canada Medical Device Licensing

Implants are classified according to their level of risk. Many surgically implanted medical devices fall within Class III or Class IV, depending on their intended purpose and characteristics.

Manufacturers must provide appropriate evidence demonstrating safety and effectiveness.

Such evidence may include mechanical testing, fatigue testing, biocompatibility studies, clinical investigations and long-term performance information.

C. Post-Market Surveillance

Post-market surveillance is essential because certain implant complications emerge only after prolonged use.

Manufacturers must maintain complaint-handling systems, investigate reported failures and comply with applicable mandatory reporting and recall requirements.

Sections 55, 57 and 58 of the Medical Devices Regulations are particularly relevant to distribution records, complaint handling and recall procedures.

4. Important International Technical Standards

A. ISO 14630

ISO 14630 establishes general requirements for non-active surgical implants, including safety, performance, design, material selection and risk management.

B. ISO 10993

ISO 10993 establishes biological evaluation requirements for medical devices.

It addresses biocompatibility, degradation products, toxicity, implantation effects and chemical characterization.

C. ISO 5840

ISO 5840 addresses cardiovascular implants, particularly prosthetic heart valves.

It establishes requirements relating to mechanical durability, structural integrity, functional performance and clinical evaluation.

D. ISO 14708

ISO 14708 establishes safety and performance requirements for active implantable medical devices, including pacemakers and implantable cardioverter-defibrillators.

E. ISO 14801

ISO 14801 provides a dynamic loading test method for endosseous dental implants.

It evaluates fatigue resistance, mechanical strength and the performance of implant components under repeated loading.

5. Major Factors Affecting Implant Durability

A. Material Degradation

Implants manufactured using titanium, stainless steel, cobalt-chromium alloys, ceramics and polymers may experience degradation over time.

Degradation may result in corrosion, chemical breakdown, particle release and reduced structural strength.

B. Mechanical Fatigue

Repeated loading and unloading may cause cracks, fractures, deformation and loosening.

This is particularly important in hip and knee replacement implants.

C. Wear and Tear

Repeated contact between implant components can produce wear particles.

These particles may cause inflammation, tissue damage and implant loosening.

D. Corrosion Resistance

Metal implants must resist corrosion in the biological environment.

Corrosion may release metallic ions and particles into surrounding tissues.

E. Biological Compatibility

Implants must remain compatible with surrounding tissues.

Long-term complications may include inflammation, fibrosis, allergic reactions, tissue necrosis and bone resorption.

F. Implant Fixation and Stability

Implants must maintain appropriate fixation within the body.

Failure of fixation may result in pain, reduced mobility, bone loss and revision surgery.

6. Testing and Validation Requirements

Manufacturers should establish comprehensive testing programmes, including:

Accelerated durability testing.

Mechanical fatigue testing.

Wear testing.

Corrosion resistance testing.

Biocompatibility testing.

Structural integrity testing.

Long-term clinical follow-up.

Failure analysis.

Laboratory testing should be supported by appropriate clinical evidence. Accelerated testing alone cannot guarantee a specific number of years of clinical service.

7. Manufacturer Responsibilities

Manufacturers have several legal responsibilities.

A. Safe Product Design

Manufacturers must design implants that are reasonably safe for their intended use.

B. Appropriate Testing

Manufacturers must generate sufficient evidence to establish safety, effectiveness and expected useful life.

C. Accurate Warnings

Manufacturers must communicate material risks, known complications, expected lifespan and relevant follow-up requirements.

D. Post-Market Monitoring

Manufacturers must investigate complaints, identify patterns of premature failure and implement corrective action where necessary.

E. Mandatory Reporting

Manufacturers must comply with applicable incident-reporting requirements under Canadian medical device legislation.

8. Patient Rights and Long-Term Monitoring

Patients receiving implants have important rights, including:

Receiving information about expected implant performance.

Understanding known risks and possible complications.

Receiving appropriate clinical follow-up.

Accessing relevant implant identification information.

Being informed about applicable recalls and safety notices.

Receiving appropriate medical care when complications arise.

Monitoring may involve clinical examinations, imaging, blood tests where medically indicated and functional assessments.

9. Important Case Laws

Case 1: Hollis v. Dow Corning Corp., [1995] 4 SCR 634

Court: Supreme Court of Canada.

Facts: The plaintiff received silicone breast implants manufactured by Dow Corning Corporation. One implant ruptured, resulting in complications. The plaintiff alleged negligent manufacturing and inadequate warnings.

Legal Issue: Whether the manufacturer had a duty to warn patients about known and foreseeable risks associated with its implants.

Judgment: The Supreme Court recognized the manufacturer's duty to provide adequate warnings about product dangers.

Legal Principle: Manufacturers must communicate material safety risks and cannot ignore important information concerning potential product failure.

Importance: This case establishes an important foundation for manufacturer responsibility concerning implant safety and long-term risk communication.

Case 2: Jones v. Zimmer GMBH, 2016 BCSC 1847

Court: Supreme Court of British Columbia.

Facts: The litigation concerned the Zimmer Durom Cup hip implant and allegations of premature failure associated with inadequate bone adhesion.

Legal Issue: Whether alleged premature implant failure and associated injuries justified legal compensation.

Judgment: The court approved a proposed class-action settlement.

Legal Principle: Premature implant failure must be distinguished from ordinary deterioration associated with the expected useful life of a medical device.

Importance: The case highlights the importance of implant durability expectations and post-market monitoring.

Case 3: McSherry v. Zimmer GMBH, 2014 ONSC 5527

Court: Ontario Superior Court of Justice.

Facts: The litigation involved allegations concerning premature failure of the Zimmer Durom Cup hip implant.

Legal Issue: Whether common issues concerning alleged implant defects and manufacturer responsibility could be considered through class proceedings.

Judgment: The court granted certification of the proposed class action.

Legal Principle: Common questions concerning alleged design, manufacturing and safety defects may be addressed through class proceedings when certification requirements are satisfied.

Importance: This case demonstrates the importance of collective legal remedies for patients affected by potentially defective implants.

Case 4: Dine v. Biomet Inc., 2015 ONSC 7050

Court: Ontario Superior Court of Justice.

Facts: The case involved allegations concerning Biomet metal-on-metal hip implant systems and their alleged premature failure.

Legal Issue: Whether allegations concerning implant design, manufacturing and warnings raised common legal questions.

Judgment: The court certified the proposed class proceeding after considering the applicable requirements.

Legal Principle: Common allegations concerning medical implant defects may be considered collectively where the legal requirements for class proceedings are established.

Importance: The case emphasizes the need for long-term performance monitoring and investigation of implant complications.

Case 5: Crisante v. DePuy Orthopaedics, 2021 ONSC 3703

Court: Ontario Superior Court of Justice.

Facts: The litigation involved DePuy ASR metal-on-metal hip implants, which were recalled in 2010 following concerns about premature revision rates.

Legal Issue: Whether allegations concerning defective design and inadequate warnings justified compensation for affected patients.

Judgment: The court approved a $15.5 million settlement.

Legal Principle: Premature revision rates and post-market clinical information are important considerations in evaluating medical implant safety.

Importance: This case demonstrates the importance of identifying unexpected implant failure rates and communicating safety concerns.

Note: The decisions in Jones, McSherry, Dine and Crisante primarily concern class-action proceedings or settlement approval. They should not be treated as final findings of manufacturer liability for every alleged defect.

10. Legal Liability for Premature Implant Failure

A. Product Liability

Manufacturers may face liability where implants contain manufacturing defects, defective designs or inadequate warnings.

B. Negligence

Manufacturers may be liable where they fail to exercise reasonable care in designing, testing, manufacturing or monitoring implants.

C. Failure to Warn

Failure to disclose known or foreseeable risks concerning premature failure, corrosion, degradation and revision surgery may create legal liability.

D. Regulatory Liability

Non-compliance with applicable medical device requirements may lead to regulatory enforcement, recalls and other corrective measures.

E. Professional Liability

Healthcare professionals may also face liability for negligent implant selection, implantation or follow-up.

11. Challenges in Establishing Long-Term Durability Standards

Several challenges affect implant durability regulation:

Long clinical observation periods.

Differences in patient age, weight and physical activity.

Rapid technological innovation.

Limitations of laboratory testing.

Differences in implant lifespan expectations.

Incomplete post-market data.

High costs of long-term clinical research.

12. Recommendations for Strengthening Implant Durability Regulation

Establish device-specific durability requirements.

Require scientifically justified useful-life claims.

Strengthen fatigue, wear and corrosion testing.

Improve long-term clinical follow-up.

Establish effective implant registries.

Strengthen reporting of premature implant failures.

Improve patient access to implant identification records.

Increase manufacturer accountability.

Improve evaluation of degradation products.

Harmonize international durability standards.

Investigate unexpected revision rates.

Strengthen communication between manufacturers, regulators and healthcare professionals.

13. Conclusion

Long-term durability standards in implants are essential for protecting patients and ensuring medical device reliability.

The Canadian Medical Devices Regulations provide an important legal foundation, particularly through Section 13, which addresses deterioration of device characteristics and performance during the projected useful life of a medical device.

International standards such as ISO 14630, ISO 10993, ISO 5840, ISO 14708 and ISO 14801 provide additional technical requirements for evaluating mechanical strength, biological compatibility, corrosion resistance and structural reliability.

Judicial decisions such as Hollis v. Dow Corning Corp., Jones v. Zimmer GMBH, McSherry v. Zimmer GMBH, Dine v. Biomet Inc. and Crisante v. DePuy Orthopaedics demonstrate the legal importance of implant safety, manufacturer warnings, premature failure and post-market monitoring.

Ultimately, effective implant durability regulation requires continuous cooperation between manufacturers, healthcare professionals, regulators, researchers and patients. Implants must be adequately tested before commercialization and monitored throughout their intended useful life.

14. References and Legal Sources

Food and Drugs Act, R.S.C. 1985, c. F-27.

Medical Devices Regulations, SOR/98-282.

ISO 14630 – Non-Active Surgical Implants.

ISO 10993 – Biological Evaluation of Medical Devices.

ISO 5840 – Cardiovascular Implants.

ISO 14708 – Active Implantable Medical Devices.

ISO 14801 – Dentistry: Dynamic Loading Test for Endosseous Dental Implants.

Hollis v. Dow Corning Corp., [1995] 4 SCR 634.

Jones v. Zimmer GMBH, 2016 BCSC 1847.

McSherry v. Zimmer GMBH, 2014 ONSC 5527.

Dine v. Biomet Inc., 2015 ONSC 7050.

Crisante v. DePuy Orthopaedics, 2021 ONSC 3703.

End of Detailed Explanation.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT